OPTIMIZATION OF CYSTITIS DIAGNOSIS AND TREATMENT BASED ON PATHOMORPHOLOGICAL CHARACTERISTICS
Ключевые слова:
Keywords: cystitis, histopathology, diagnosis, individualized treatment, recurrence, inflammationАннотация
Abstract. This study explores the optimization of cystitis diagnosis and treatment by integrating pathomorphological analysis into the clinical workflow. A total of 80 patients aged 25 to 55 years were divided into two groups: one receiving standard therapy, and the other receiving individualized treatment based on histological findings. Mucosal biopsies obtained via cystoscopy were classified into acute inflammation, chronic interstitial cystitis, and granular cystitis with metaplasia. The tailored treatment group demonstrated significantly improved clinical outcomes, higher urine sterility rates, and reduced recurrence compared to the control group. These results indicate that histologically guided management enhances treatment precision and efficacy in cystitis. Incorporating pathomorphological diagnostics into routine practice may provide a foundation for more personalized and successful therapy in bladder inflammation.
Библиографические ссылки
1. Isroilovich A. E. et al. The Role And Importance Of Gliah Neurotrophical Factors In Early Diagnosis Of Parkinson Disease //Texas Journal of Medical Science. – 2022. – Т. 5. – С. 1-6.
2. Abdukodirov E. I. et al. Study of bioelectric activity of the brain in patients with neurosensorius deafness //Oriental Journal of Medicine and Pharmacology. – 2022. – Т. 2. – №. 05. – С. 10-19.
3. Isroilovich A. E., Kodirovich K. N., Jumanazarovich M. R. Hereditary Diseases of the Nervous System, Their Prevalence and Epidemiological Status //Central Asian Journal of Medical and Natural Science. – 2022. – Т. 3. – №. 6. – С. 127-132.
4. Abdukodirov E. I., Khalimova K. M., Matmurodov R. J. Hereditary-Genealogical Features of Parkinson's Disease and Their Early Detection of the Disease //International Journal of Health Sciences. – №. I. – С. 4138-4144.
5. Abdukodirov E. I. et al. Pain syndromes during covid-19 and its consequences //Oriental Journal of Medicine and Pharmacology. – 2022. – Т. 2. – №. 05. – С. 36-44.
6. Абдукадиров, Э. И., Матмуродов, Р. Ж., Халимова, Х. М., & Муминов, Б. А. (2021). Паркинсон касаллигининг ирсий-генеологик хусусиятлари ва уларни касалликни эрта аниқлашдаги ўрни. Журнал неврологии и нейрохирургических исследований, 2(4).
7. Абдукадиров, Элдор Исроилавич, et al. Паркинсон касаллигининг ирсий-генеологик хусусиятлари ва уларни касалликни эрта аниқлашдаги ўрни." журнал неврологии и нейрохирургических исследований 2.4 (2021).
8. Hanno, P. M., Erickson, D., Moldwin, R., & Faraday, M. M. (2015). Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. The Journal of Urology, 193(5), 1545–1553.
9. Nickel, J. C., Shoskes, D., Irvine-Bird, K., & Krska, L. (2010). Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: A key to classification and potentially improved management. The Journal of Urology, 184(6), 2111–2117.
10. Giel, D. W., & Clemens, J. Q. (2010). Evidence-based management of recurrent uncomplicated urinary tract infections in women. Urologic Clinics of North America, 37(3), 253–262.
11. Fall, M., Baranowski, A. P., Elneil, S., Engeler, D., Hughes, J., Messelink, E. J., ... & Wyndaele, J. J. (2010). Guidelines on chronic pelvic pain. European Association of Urology.
12. Liu, H. T., & Kuo, H. C. (2008). Urinary nerve growth factor levels as a biomarker for interstitial cystitis/bladder pain syndrome and its correlation with clinical characteristics. Urology, 72(5), 1041–1045.
13. van de Merwe, J. P. (2007). Interstitial cystitis and systemic autoimmune diseases. Nature Clinical Practice Urology, 4(9), 484–491.
